5
Participants
Start Date
July 31, 2004
Primary Completion Date
April 30, 2009
Study Completion Date
April 30, 2009
miglustat
Target dose of 320 mg/m\^2/day (divided in 3 doses) will be based on the Body Surface Area (BSA). For children with a BSA \> 1.3, 200 mg TID will be administered. For children with a BSA of 0.8-1.3, 100 mg TID will be administered.
The Hospital for Sick Children, Toronto
Collaborators (1)
Actelion
INDUSTRY
The Hospital for Sick Children
OTHER